BLLN

KOLLURI KRISHNA KITTU

CIK: 0001270521

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

BLLN Gets Price Target Hike and New Study Data. BillionToOne reported that its Northstar Response test showed results comparable to or better than tumor-informed assays in a new peer-reviewed study. Guggenheim raised its price target to $128, while other analysts noted rising reimbursement risks. The stock is currently trading near its support level of $95.81.

this person other insiders at BLLN

Transaction History

BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▲ Buy$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell$0
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▼ Sell—
BLLN▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.